Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF
Having 2 trials that both show benefits of SGLT2 inhibitors in heart failure hospitalizations can only encourage the use of these drugs, said John McMurray, MD, FRCP, FESC, professor of medical cardiology in the Institute of Cardiovascular and Medical Sciences at the University of Glasgow.
Watch video Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF online without registration, duration hours minute second in high quality. This video was added by user AJMCtv MJH 31 August 2020, don't forget to share it with your friends and acquaintances, it has been viewed on our site 1,924 once and liked it 12 people.